
51 - 200 employees
Founded 2017
🧬 Biotechnology
💊 Pharmaceuticals
🤖 Artificial Intelligence
Biotechnology • Pharmaceuticals • Artificial Intelligence
Asimov is a synthetic biology company that provides an integrated platform combining engineered GMP host cells, validated genetic parts libraries, DNA construction, lab services, and cloud-based design software to accelerate development and manufacture of biologics, gene therapies, and cell therapies. The company uses data-driven models and AI to design, simulate, and optimize genetic systems and offers both tools-for-in-house development and full-service cell line and process development from its Boston lab. Asimov partners with biotech and pharma customers to deliver clonal producer cell banks, DNA, and regulatory documentation, aiming to streamline therapeutic development and scalable manufacturing.
🕒 April 12